STAT3 inhibitor BBI608 enhances the antitumor effect of gefitinib on EGFR-mutated non-small cell lung cancer cells
Keyword(s):
Keyword(s):
2010 ◽
Keyword(s):
Keyword(s):
2017 ◽
Vol 16
(3)
◽
pp. 3581-3586
◽
Keyword(s):
2019 ◽
Vol Volume 13
◽
pp. 1145-1153
◽
Keyword(s):
Keyword(s):
Keyword(s):
2017 ◽
Vol 38
(11)
◽
pp. 1512-1520
◽
Keyword(s):
Keyword(s):
2015 ◽
Vol 10
(2)
◽
pp. 126-130
Keyword(s):